Monitor subsequent F-1 amendments for the proposed price range and number of shares, which will determine the IPO's size and the resulting deleveraging impact on the company's balance sheet.
Executive Summary
Aggreko Inc. filed Amendment No. 2 to its F-1 registration statement for an initial public offering of ordinary shares to be listed on the NYSE under the symbol AGKO. The company is a global leader in engineered energy and temperature solutions, serving over 14,000 customers in more than 80 countries. The IPO proceeds, along with a concurrent sponsor contribution, will be used to repay outstanding borrowings under its Revolving Facilities and a portion of its Senior Term Facilities, with remaining proceeds for general corporate purposes. The filing updates risk factors and financials but does not specify the proposed price range or number of shares.
Key Financial Metrics
Key Facts
- Aggreko Inc. filed Amendment No. 2 to its F-1 registration statement for an IPO of ordinary shares on the NYSE under symbol AGKO.
- The company is a Cayman Islands exempted company with operations in over 80 countries, providing engineered energy and temperature solutions.
- Net revenues were $3,416 million for FY2025 (53 weeks ended Jan 3, 2026), up 20% from $2,854 million in FY2024.
- Net loss was $(113) million for FY2025, compared to net income of $34 million in FY2024.
- Adjusted EBITDA was $1,260 million for FY2025, up from $1,055 million in FY2024; Adjusted EBITDA Margin was 37% for both years.
- Total debt was $5,885 million as of Jan 3, 2026.
- IPO proceeds, together with a concurrent sponsor contribution and director co-invest issuances, will be used to repay Revolving Facilities and a portion of Senior Term Facilities, retaining $300 million cash on balance sheet.
- The filing does not specify the proposed price range or number of shares to be offered.
- Underwriters include Goldman Sachs, J.P. Morgan, BofA Securities, Barclays, Morgan Stanley, Jefferies, and others.
- Certain underwriters are deemed to have a conflict of interest under FINRA Rule 5121 as affiliates are lenders under the company's credit facilities.
Financial Impact
IPO proceeds expected to be used to repay $612 million in Revolving Facilities and a portion of Senior Term Facilities ($2,110 million USD-denominated and €1,692 million euro-denominated as of Oct 3, 2026), with $300 million retained as cash.
Risk Factors
- No price range or share count specified, leaving IPO valuation and dilution unknown.
- Company has substantial leverage ($5.9 billion debt as of Jan 3, 2026) and reported a net loss of $(113) million in FY2025.
- Identified material weaknesses in internal control over financial reporting.
- Foreign private issuer status provides reduced disclosure requirements compared to U.S. domestic companies.
- Sponsors TDR Capital and I Squared Capital will retain significant control after the offering.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| F-1/A Filing (Primary) | 0001104659-26-126335 |
| Document: tmm-ex10d6.htm | 0001104659-26-126335 |
| Document: tmm-ex10d4.htm | 0001104659-26-126335 |
| Document: tmm-ex10d5.htm | 0001104659-26-126335 |
Track record
2 reports on AGKO
Filters
- Nov 12, 20264d ago F-1/A Neutral 3/10 Viewing No price data
- Sep 17, 20268w ago F-1/A Neutral 5/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers